Asia-Pacific PDX Models Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.
The key market players for Asia-Pacific PDX models market are listed below:
The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into:
The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.
The key market players for Asia-Pacific PDX models market are listed below:
- Crown Bioscience Inc.
- The Jackson Laboratory
- Champion Oncology, Inc.
- Charles River
- Oncodesign
- Wuxi AppTec
- Horizon Discovery Group plc
- Pharmatest Services
- Hera Biolabs
- EPO Berlin-Buch GmbH
- Xentech
- Urolead
- Creative Animodel
- EUROPDX
- MI Bioresearch Inc
- Aragen Bioscience
- Type
- Tumor Type
- Application
- End User
The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into:
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Thailand
- Malaysia
- Indonesia
- Philippines
- Rest of Asia Pacific
The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-Pacific Pdx Models Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach
3.1.3 Rising Need For Personalized Medicine
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization
3.2 Restraints
3.2.1 High Cost Of Pdx Models
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research
3.3 Opprtunities
3.3.1 Increasing Demand For Humanized Pdx Models
3.4 Challenges
3.4.1 Limitations Of Pdx Models
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE
6.1 Overview
6.2 Mice Models
6.3 Rat Models
7 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE
7.1 Overview
7.2 Gastrointestinal Tumor Models
7.3 Gynecological Tumor Models
7.4 Respiratory Tumor Models
7.5 Urological Tumor Models
7.6 Hematological Tumor Models
7.7 Others
8 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION
8.1 Overview
8.2 Preclinical Drug Development And Oncology Research
8.3 Biomarker Analysis
9 ASIA-PACIFIC PDX MODELS MARKET, BY END USER
9.1 Overview
9.2 Contract Research Organizations
9.3 Pharmaceutical And Biotechnology Companies
9.4 Academic And Research Institutions
10 ASIA-PACIFIC PDX MODELS MARKET, BY GEOGRAPHY
10.1 Asia Pacific
10.1.1 Japan
10.1.2 China
10.1.3 India
10.1.4 South Korea
10.1.5 Australia
10.1.6 Singapore
10.1.7 Thailand
10.1.8 Malaysia
10.1.9 Indonesia
10.1.10 Philippines
10.1.11 Rest Of Asia Pacific
11 ASIA-PACIFIC PDX MODELS MARKET, COMPANY LANDSCAPE
11.1 Company Share Analysis: Asia Pacific
12 COMPANY PROFILES
12.1 Charles River
12.1.1 Company Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation)
12.2.1 Company Overview
12.2.2 Geographic Presence
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Champion Oncology, Inc
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Company Share Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited)
12.4.1 Company Overview
12.4.2 Product Portfolio
12.4.3 Recent Developments
12.5 Creative Animodel
12.5.1 Company Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.6 Epo Berlin-Buch Gmbh
12.6.1 Company Overview
12.6.2 Product Portfolio
12.6.3 Recent Developments
12.7 Europdx
12.7.1 Company Overview
12.7.2 Geographical Presence
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 Hera Biolabs
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments
12.9 Horizon Discovery Group Plc
12.9.1 Company Overview
12.9.2 Revenue Analysis
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Mi Bioresearch Inc
12.10.1 Company Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.11 Oncodesign
12.11.1 Company Overview
12.11.2 Revenue Analysis
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Pharmatest Services Ltd
12.12.1 Company Overview
12.12.2 Geographic Presence
12.12.3 Product Portfolio
12.12.4 Recent Developments
12.13 The Jackson Laboratory
12.13.1 Company Overview
12.13.2 Revenue Analysis
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Urolead
12.14.1 Company Overview
12.14.2 Product Portfolio
12.14.3 Recent Developments
12.15 Wuxi Apptec
12.15.1 Company Overview
12.15.2 Geographic Presence
12.15.3 Product Portfolio
12.15.4 Recent Developments
12.16 Xentech
12.16.1 Company Overview
12.16.2 Product Portfolio
12.16.3 Recent Developments
13 RELATED REPORTS
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-Pacific Pdx Models Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach
3.1.3 Rising Need For Personalized Medicine
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization
3.2 Restraints
3.2.1 High Cost Of Pdx Models
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research
3.3 Opprtunities
3.3.1 Increasing Demand For Humanized Pdx Models
3.4 Challenges
3.4.1 Limitations Of Pdx Models
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE
6.1 Overview
6.2 Mice Models
6.3 Rat Models
7 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE
7.1 Overview
7.2 Gastrointestinal Tumor Models
7.3 Gynecological Tumor Models
7.4 Respiratory Tumor Models
7.5 Urological Tumor Models
7.6 Hematological Tumor Models
7.7 Others
8 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION
8.1 Overview
8.2 Preclinical Drug Development And Oncology Research
8.3 Biomarker Analysis
9 ASIA-PACIFIC PDX MODELS MARKET, BY END USER
9.1 Overview
9.2 Contract Research Organizations
9.3 Pharmaceutical And Biotechnology Companies
9.4 Academic And Research Institutions
10 ASIA-PACIFIC PDX MODELS MARKET, BY GEOGRAPHY
10.1 Asia Pacific
10.1.1 Japan
10.1.2 China
10.1.3 India
10.1.4 South Korea
10.1.5 Australia
10.1.6 Singapore
10.1.7 Thailand
10.1.8 Malaysia
10.1.9 Indonesia
10.1.10 Philippines
10.1.11 Rest Of Asia Pacific
11 ASIA-PACIFIC PDX MODELS MARKET, COMPANY LANDSCAPE
11.1 Company Share Analysis: Asia Pacific
12 COMPANY PROFILES
12.1 Charles River
12.1.1 Company Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation)
12.2.1 Company Overview
12.2.2 Geographic Presence
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Champion Oncology, Inc
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Company Share Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited)
12.4.1 Company Overview
12.4.2 Product Portfolio
12.4.3 Recent Developments
12.5 Creative Animodel
12.5.1 Company Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.6 Epo Berlin-Buch Gmbh
12.6.1 Company Overview
12.6.2 Product Portfolio
12.6.3 Recent Developments
12.7 Europdx
12.7.1 Company Overview
12.7.2 Geographical Presence
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 Hera Biolabs
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments
12.9 Horizon Discovery Group Plc
12.9.1 Company Overview
12.9.2 Revenue Analysis
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Mi Bioresearch Inc
12.10.1 Company Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.11 Oncodesign
12.11.1 Company Overview
12.11.2 Revenue Analysis
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Pharmatest Services Ltd
12.12.1 Company Overview
12.12.2 Geographic Presence
12.12.3 Product Portfolio
12.12.4 Recent Developments
12.13 The Jackson Laboratory
12.13.1 Company Overview
12.13.2 Revenue Analysis
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Urolead
12.14.1 Company Overview
12.14.2 Product Portfolio
12.14.3 Recent Developments
12.15 Wuxi Apptec
12.15.1 Company Overview
12.15.2 Geographic Presence
12.15.3 Product Portfolio
12.15.4 Recent Developments
12.16 Xentech
12.16.1 Company Overview
12.16.2 Product Portfolio
12.16.3 Recent Developments
13 RELATED REPORTS
LIST OF TABLES
Table 1 Asia-Pacific Pdx Models Market, By Type, 2016– 2025, (Usd Million)
Table 2 Asia-Pacific Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 3 Asia-Pacific Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 4 Asia-Pacific Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million)
Table 5 Asia-Pacific Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 6 Asia-Pacific Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 7 Asia-Pacific Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 8 Asia-Pacific Urological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 9 Asia-Pacific Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 10 Asia-Pacific Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 11 Asia-Pacific Pdx Models Market, By Application, 2016– 2025 (Usd Million)
Table 12 Asia-Pacific Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 13 Asia-Pacific Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 14 Asia-Pacific Pdx Models Market, By End User, 2016– 2025, (Usd Million)
Table 15 Asia-Pacific Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million)
Table 16 Asia-Pacific Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 17 Asia-Pacific Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million)
Table 18 Asia Pacific Pdx Models Market, By Country, 2016 – 2025, (Usd Million)
Table 19 Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 20 Asia Pacific Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 21 Asia Pacific Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 22 Asia Pacific Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 23 Japan Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 24 Japan Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 25 Japan Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 26 Japan Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 27 China Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 28 China Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 29 China Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 30 China Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 31 India Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 32 India Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 33 India Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 34 India Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 35 South Korea Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 36 South Korea Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 37 South Korea Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 38 South Korea Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 39 Australia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 40 Australia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 41 Australia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 42 Australia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 43 Singapore Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 44 Singapore Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 45 Singapore Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 46 Singapore Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 47 Thailand Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 48 Thailand Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 49 Thailand Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 50 Thailand Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 51 Malaysia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 52 Malaysia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 53 Malaysia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 54 Malaysia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 55 Indonesia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 56 Indonesia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 57 Indonesia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 58 Indonesia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 59 Philippines Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 60 Philippines Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 61 Philippines Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 62 Philippines Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 63 Rest Of Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 1 Asia-Pacific Pdx Models Market, By Type, 2016– 2025, (Usd Million)
Table 2 Asia-Pacific Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 3 Asia-Pacific Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 4 Asia-Pacific Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million)
Table 5 Asia-Pacific Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 6 Asia-Pacific Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 7 Asia-Pacific Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 8 Asia-Pacific Urological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 9 Asia-Pacific Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 10 Asia-Pacific Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 11 Asia-Pacific Pdx Models Market, By Application, 2016– 2025 (Usd Million)
Table 12 Asia-Pacific Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 13 Asia-Pacific Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 14 Asia-Pacific Pdx Models Market, By End User, 2016– 2025, (Usd Million)
Table 15 Asia-Pacific Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million)
Table 16 Asia-Pacific Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 17 Asia-Pacific Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million)
Table 18 Asia Pacific Pdx Models Market, By Country, 2016 – 2025, (Usd Million)
Table 19 Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 20 Asia Pacific Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 21 Asia Pacific Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 22 Asia Pacific Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 23 Japan Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 24 Japan Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 25 Japan Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 26 Japan Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 27 China Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 28 China Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 29 China Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 30 China Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 31 India Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 32 India Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 33 India Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 34 India Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 35 South Korea Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 36 South Korea Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 37 South Korea Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 38 South Korea Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 39 Australia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 40 Australia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 41 Australia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 42 Australia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 43 Singapore Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 44 Singapore Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 45 Singapore Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 46 Singapore Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 47 Thailand Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 48 Thailand Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 49 Thailand Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 50 Thailand Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 51 Malaysia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 52 Malaysia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 53 Malaysia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 54 Malaysia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 55 Indonesia Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 56 Indonesia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 57 Indonesia Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 58 Indonesia Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 59 Philippines Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 60 Philippines Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 61 Philippines Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 62 Philippines Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 63 Rest Of Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
LIST OF FIGURES
Figure 1 Asia-Pacific Pdx Models Market: Segmentation
Figure 2 Asia-Pacific Pdx Models Market: Data Triangulation
Figure 3 Asia-Pacific Pdx Models Market: Research Snapshot
Figure 4 Asia-Pacific Pdx Models Market: Bottom Up Approach
Figure 5 Asia-Pacific Pdx Models Market: Top Down Approach
Figure 6 Asia-Pacific Pdx Models Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market
Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17:
Figure 9 Asia-Pacific Pdx Models Market: Segmentation
Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025
Figure 11 Mice Models Is Expected To Account For The Largest Share Of The Asia-Pacific Pdx Models Market In 2018 & 2025
Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025
Figure 13 Asia-Pacific Pdx Models Market: By Type, 2017
Figure 14 Asia-Pacific Pdx Models Market: By Tyumor Type, 2017
Figure 15 Asia-Pacific Pdx Models Market: By Application, 2017
Figure 16 Asia-Pacific Pdx Models Market: By End User, 2017
Figure 17 Asia Pacific Pdx Models Market Snapshot (2017)
Figure 18 Asia Pacific Pdx Models Market: By Country (2017)
Figure 19 Asia Pacific Pdx Models Market: By Country (2018 & 2025)
Figure 20 Asia Pacific Pdx Models Market: By Country (2017 & 2025)
Figure 21 Asia Pacific Pdx Models Market: By Type (2018-2025)
Figure 22 Asia-Pacific Pdx Models Market: Company Share 2017 (%)
Figure 1 Asia-Pacific Pdx Models Market: Segmentation
Figure 2 Asia-Pacific Pdx Models Market: Data Triangulation
Figure 3 Asia-Pacific Pdx Models Market: Research Snapshot
Figure 4 Asia-Pacific Pdx Models Market: Bottom Up Approach
Figure 5 Asia-Pacific Pdx Models Market: Top Down Approach
Figure 6 Asia-Pacific Pdx Models Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market
Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17:
Figure 9 Asia-Pacific Pdx Models Market: Segmentation
Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025
Figure 11 Mice Models Is Expected To Account For The Largest Share Of The Asia-Pacific Pdx Models Market In 2018 & 2025
Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025
Figure 13 Asia-Pacific Pdx Models Market: By Type, 2017
Figure 14 Asia-Pacific Pdx Models Market: By Tyumor Type, 2017
Figure 15 Asia-Pacific Pdx Models Market: By Application, 2017
Figure 16 Asia-Pacific Pdx Models Market: By End User, 2017
Figure 17 Asia Pacific Pdx Models Market Snapshot (2017)
Figure 18 Asia Pacific Pdx Models Market: By Country (2017)
Figure 19 Asia Pacific Pdx Models Market: By Country (2018 & 2025)
Figure 20 Asia Pacific Pdx Models Market: By Country (2017 & 2025)
Figure 21 Asia Pacific Pdx Models Market: By Type (2018-2025)
Figure 22 Asia-Pacific Pdx Models Market: Company Share 2017 (%)
